Organovo Holdings, Inc. (NASDAQ:ONVO) is now up 24.65% compared to a 12-month low of $1.32. We have seen the price to move 9.27% higher and get settled at $1.65 on 12/01/2017. At recent session, it appeared stuck in a range of $1.47 to $1.7. This company shares are 51.52% off its target price of $2.5 and the current market capitalization stands at $189.25M. The recent change has given its price a -1.01% deficit over SMA 50 and -59.56% deficit over its 52-week high. The stock witnessed 5.77% gains, -19.51% declines and -44.26% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ONVO’s volatility during a week at 10% and during a month it has been found around 7.35%.Organovo Holdings, Inc. (ONVO) Top Holders
Institutional investors currently hold around $46 million or 26.7% in ONVO stock. Look at its top three institutional owners. Blackrock Inc. owns $12.98 million in Organovo Holdings, Inc., which represents roughly 6.86% of the company’s market cap and approximately 28.22% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 4,556,006 shares of the stock are valued at $7.52 million. The third largest holder is Ark Investment Management Llc, which currently holds $4.33 million worth of this stock and that ownership represents nearly 2.29% of its market capitalization.Organovo Holdings, Inc. 13F Filings
At the end of 9/30/2017 reporting period, 52 institutional holders increased their position in Organovo Holdings, Inc. (NASDAQ:ONVO) by some 3,896,517 shares, 34 decreased positions by 1,367,306 and 44 held positions by 22,719,263. That puts total institutional holdings at 27,983,086 shares, according to SEC filings. The stock grabbed 12 new institutional investments totaling 1,093,409 shares while 10 institutional investors sold out their entire positions totaling 533,858 shares.Organovo Holdings, Inc. (NASDAQ:ONVO) Insider Trades
Multiple company employees have indulged in significant insider trading. Organovo Holdings, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chairman, CEO and President Murphy Keith has sold 25,000 shares of Organovo Holdings, Inc. (ONVO) in trading session dated Feb. 09, 2017. These shares are worth $92,000 and were traded at $3.68 each. The SEC filing shows that Murphy Keith performed a sale of 25,000 shares. The Chairman, CEO and President disposed these shares by way of transaction on Jan. 24, 2017. The company’s shares were given away at $3.51 per share worth to an income of some $87,750 on account of Murphy Keith.
Chairman, CEO and President, Murphy Keith, sold 50,000 common shares of Organovo Holdings, Inc. (ONVO) in the open market. In a transaction dated Dec. 14, 2016, the shares were put up for sale at an average price of $3.72, raking in a sum of $186,000. After this sale, 6,063,915 common shares of ONVO are directly owned by the insider, with total stake valued at $10,005,460.
In the transaction dated Aug. 05, 2016, the great number of shares disposed came courtesy the CSO & EVP Pre-Clinical Dev; David Eric disposed a total of 20,000 shares at an average price of $4.55, amounting to approximately $91,000. The insider now directly owns 706,306 shares worth $1,165,405.Organovo Holdings, Inc. (ONVO) Analyst Guide
Several analysts have released their opinion on Organovo Holdings, Inc. (NASDAQ:ONVO), with 1 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2 average brokerage recommendation.